Purdue Pharma’s Payments to Sacklers Soared Amid Opioid Crisis by BY JAN HOFFMAN AND DANNY HAKIM


A new audit finds that the family directed $10.7 billion from the drugmaker to family-controlled trusts and holding companies, as legal pressure tightened around Purdue.

Published: December 16, 2019 at 11:49PM

from NYT Health https://ift.tt/35taG0z